VXL.V -- High risk/high reward Coronavirus vaccine developer
Updated
VXL is the volume leader on TSX-V today on the news of Coronavirus vaccine patent application.
+21.74% so far. Likely held down by warrant sellers but could be a serious runner once they are out.
12M mkt cap is cheap compared to other biomed stocks that ran on Coronavirus related news.
Very decent float at 89M shares.
+21.74% so far. Likely held down by warrant sellers but could be a serious runner once they are out.
12M mkt cap is cheap compared to other biomed stocks that ran on Coronavirus related news.
Very decent float at 89M shares.
Note
Worthy of note:Vaxil Bio is one of the few companies named on the WHO Coronavirus Vaccine Developers list and was recently part of the meeting at the White House. It is also mentioned in multiple scientific/news articles in Canada/US/EU. There's talk of multi-million $$ grants currently being allocated to various vaccine makers/researchers and Vaxil is being mentioned. Google "Analysis: The European Fight Against The COVID-19 Coronavirus" for an example.
Possible short-term catalysts: multi-million $$ grants, partnership announcement, lab test results... I like the risk/reward at current mkt cap!
Note
The WHO has just declared a pandemic!Trade closed: target reached
Booked 70% profit here. Lovely trade!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.